AMYPAD PNHS Data Use Agreement
Accepted with a data access request that the AMYPAD Data Sharing and Publication Committee reviews. Users act as data processors, must not re-identify participants or pass the data on, may share derived data only at group level, and must credit AMYPAD as set out in the PNHS Publication Policy.
Our reading of the license, not legal advice. Before you use the data, read the original license and confirm that your use is allowed. We take no responsibility for how you use a dataset. Full disclaimer
What you can do
- Not stated
- Train ML models Not stated
- Yes
- Yes
What you can share
- No
- Conditional
- Not stated
What you must do
- Yes
- Share alike No
- Yes
- Conditional
- Manuscript review No
- Release code No
- Return results No
- Delete after use No
Limits
- Yes
- No
Datasets under this license
- AMYPAD PNHS
European cohort of 3,368 older adults without dementia from 10 parent cohorts, with florbetaben or flutemetamol amyloid PET for 1,620 and longitudinal multimodal brain MRI (T1w, FLAIR, T2*, SWI, diffusion, fMRI, ASL), plus clinical, cognitive, CSF and genetic data. Access by reviewed request.